Abstract
The ability to grow human cells ex vivo is the basis for remarkable advances in fields ranging from cell biology to medicine. From Gey’s demonstration that human cancer cells can be cultured in vitro [1] to Thomson’s derivation of human embryonic stem (hES) cells [2] to Yamanaka’s reprogramming of fibroblasts to induced pluripotent stem (iPS) cells [3], new opportunities have emerged with access to renewable supplies of human cells. Human pluripotent stem cells (hPS cells, which consist of hES and iPS cells) have the notable capacity to both self-renew indefinitely and differentiate into many different cell types [2–4]. These attributes of hPS cells have engendered excitement because of the cell’s potential applications. For example, they could advance regenerative medicine by serving as renewable sources of specialized human cell types for repair of damaged tissue or organs. In addition, they could be used in drug discovery to identify drug leads and to evaluate lead metabolism and toxicity [5, 6]. Moreover, patient-derived iPS cell lines provide the means to understand disease progression and devise new therapies [7]. Finally, the study of hPS cells can reveal the molecular mechanisms underlying human development.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Gey GO, Coffman WD, Kubicek MT (1952) Tissue culture studies of the proliferative capacity of human cervical carcinoma and normal epithelium. Cancer Res 12:264–265
Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM (1998) Embryonic stem cell lines derived from human blastocysts. Science 282:1145–1147
Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131:861–872. doi:10.1016/j.cell.2007.11.019
Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, Nie J, Jonsdottir GA, Ruotti V, Stewart R, Slukvin II, Thomson JA (2007) Induced pluripotent stem cell lines derived from human somatic cells. Science 318:1917–1920. doi:10.1126/science.1151526
Klimanskaya I, Rosenthal N, Lanza R (2008) Derive and conquer: sourcing and differentiating stem cells for therapeutic applications. Nat Rev Drug Discov 7:131–142. doi:10.1038/nrd2403
Teo AKK, Vallier L (2010) Emerging use of stem cells in regenerative medicine. Biochem J 428:11–23. doi:10.1042/bj20100102
Inoue H, Yamanaka S (2011) The use of induced pluripotent stem cells in drug development. Clin Pharmacol Ther 89:655–661. doi:10.1038/clpt.2011.38
Eagle H (1955) Nutrition needs of mammalian cells in tissue culture. Science 122:501–514
Ludwig TE, Bergendahl V, Levenstein ME, Yu J, Probasco MD, Thomson JA (2006) Feeder-independent culture of human embryonic stem cells. Nat Methods 3:637–646. doi:10.1038/nmeth902
Yao S, Chen S, Clark J, Hao E, Beattie GM, Hayek A, Ding S (2006) Long-term self-renewal and directed differentiation of human embryonic stem cells in chemically defined conditions. Proc Natl Acad Sci USA 103:6907–6912. doi:10.1073/pnas.0602280103
Wang L, Schulz TC, Sherrer ES, Dauphin DS, Shin S, Nelson AM, Ware CB, Zhan M, Song CZ, Chen X, Brimble SN, McLean A, Galeano MJ, Uhl EW, D’Amour KA, Chesnut JD, Rao MS, Blau CA, Robins AJ (2007) Self-renewal of human embryonic stem cells requires insulin-like growth factor-1 receptor and ERBB2 receptor signaling. Blood 110:4111–4119. doi:10.1182/blood-2007-03-082586
Xu CH, Inokuma MS, Denham J, Golds K, Kundu P, Gold JD, Carpenter MK (2001) Feeder-free growth of undifferentiated human embryonic stem cells. Nat Biotechnol 19:971–974
Kleinman HK, Martin GR (2005) Matrigel: basement membrane matrix with biological activity. Semin Cancer Biol 15:378–386. doi:10.1016/j.semcancer.2005.05.004
Villa-Diaz LG, Nandivada H, Ding J, Nogueira-De-Souza NC, Krebsbach PH, O’Shea KS, Lahann J, Smith GD (2010) Synthetic polymer coatings for long-term growth of human embryonic stem cells. Nat Biotechnol 28:581–583. doi:10.1038/nbt.1631
Brafman DA, Chang CW, Fernandez A, Willert K, Varghese S, Chien S (2010) Long-term human pluripotent stem cell self-renewal on synthetic polymer surfaces. Biomaterials 31: 9135–9144. doi:10.1016/j.biomaterials.2010.08.007
Irwin EF, Gupta R, Dashti DC, Healy KE (2011) Engineered polymer-media interfaces for the long-term self-renewal of human embryonic stem cells. Biomaterials 32:6912–6919. doi:10.1016/j.biomaterials.2011.05.058
Mei Y, Saha K, Bogatyrev SR, Yang J, Hook AL, Kalcioglu ZI, Cho S-W, Mitalipova M, Pyzocha N, Rojas F, Van Vliet KJ, Davies MC, Alexander MR, Langer R, Jaenisch R, Anderson DG (2010) Combinatorial development of biomaterials for clonal growth of human pluripotent stem cells. Nat Mater 9:768–778. doi:10.1038/nmat2812
Pierschbacher MD, Ruoslahti E (1984) Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule. Nature (Lond) 309:30–33
Klim JR, Li L, Wrighton PJ, Piekarczyk MS, Kiessling LL (2010) A defined glycosaminoglycan-binding substratum for human pluripotent stem cells. Nat Methods 7:989–994. doi:10.1038/nmeth.1532
Li YJ, Chung EH, Rodriguez RT, Firpo MT, Healy KE (2006) Hydrogels as artificial matrices for human embryonic stem cell self-renewal. J Biomed Mater Res A 79:1–5. doi:10.1002/jbm.a.30732
Kolhar P, Kotamraju VR, Hikita ST, Clegg DO, Ruoslahti E (2010) Synthetic surfaces for human embryonic stem cell culture. J Biotechnol. doi:10.1016/j.jbiotec.2010.01.016
Melkoumian Z, Weber JL, Weber DM, Fadeev AG, Zhou Y, Dolley-Sonneville P, Yang J, Qiu L, Priest CA, Shogbon C, Martin AW, Nelson J, West P, Beltzer JP, Pal S, Brandenberger R (2010) Synthetic peptide-acrylate surfaces for long-term self-renewal and cardiomyocyte differentiation of human embryonic stem cells. Nat Biotechnol 28:606–610. doi:10.1038/nbt.1629
Orner BP, Derda R, Lewis RL, Thomson JA, Kiessling LL (2004) Arrays for the combinatorial exploration of cell adhesion. J Am Chem Soc 126:10808–10809. doi:10.1021/ja0474291
Love JC, Estroff LA, Kriebel JK, Nuzzo RG, Whitesides GM (2005) Self-assembled monolayers of thiolates on metals as a form of nanotechnology. Chem Rev 105:1103–1169
Derda R, Li L, Orner BP, Lewis RL, Thomson JA, Kiessling LL (2007) Defined substrates for human embryonic stem cell growth identified from surface arrays. ACS Chem Biol 2:347–355. doi:10.1021/cb700032u
Luk YY, Kato M, Mrksich M (2000) Self-assembled monolayers of alkanethiolates presenting mannitol groups are inert to protein adsorption and cell attachment. Langmuir 16:9604–9608
Derda R, Wherritt DJ, Kiessling LL (2007) Solid-phase synthesis of alkanethiols for the preparation of self-assembled monolayers. Langmuir ACS J Surfaces Colloids 23:11164–11167. doi:10.1021/la701386v
Derda R, Musah S, Orner BP, Klim JR, Li L, Kiessling LL (2010) High-throughput discovery of synthetic surfaces that support proliferation of pluripotent cells. J Am Chem Soc. doi:10.1021/ja906089g
Ludwig TE, Levenstein ME, Jones JM, Berggren WT, Mitchen ER, Frane JL, Crandall LJ, Daigh CA, Conard KR, Piekarczyk MS, Llanas RA, Thomson JA (2006) Derivation of human embryonic stem cells in defined conditions. Nat Biotechnol 24:185–187. doi:10.1038/nbt1177
Watanabe K, Ueno M, Kamiya D, Nishiyama A, Matsumura M, Wataya T, Takahashi JB, Nishikawa S, Nishikawa S, Muguruma K, Sasai Y (2007) A ROCK inhibitor permits survival of dissociated human embryonic stem cells. Nat Biotechnol 25:681–686. doi:10.1038/nbt1310
Berg JM (2011) Fiscal Year 2012 Budget Request, National Institutes of Health. In: Health NI (ed) NIGMS Director’s Statements to Appropriations Subcommittees, National Institute of General Medical Sciences
Esko JD, Kimata K, Lindahl U (2009) Proteoglycans and Sulfated Glycosaminoglycans. In: Varki A, Cummings RD, Esko JD, Freeze HH, Stanley P, Bertozzi CR, et al., (eds.). Essentials of Glycobiology. 2nd ed. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press;pp. 229–248
Gama CI, Tully SE, Sotogaku N, Clark PM, Rawat M, Vaidehi N, Goddard WA, Nishi A, Hsieh-Wilson, LC (2006) Sulfation patterns of glycosaminoglycans encode molecular recognition and activity. Nat Chem Biol 2(9):467–473. doi: 10.1038/nchembio810. PubMed PMID: 16878128
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer
About this paper
Cite this paper
Kiessling, L.L. (2012). Tailored Synthetic Surfaces to Control Human Pluripotent Stem Cell Self-Renewal. In: Shibasaki, M., Iino, M., Osada, H. (eds) Chembiomolecular Science. Springer, Tokyo. https://doi.org/10.1007/978-4-431-54038-0_15
Download citation
DOI: https://doi.org/10.1007/978-4-431-54038-0_15
Published:
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-54037-3
Online ISBN: 978-4-431-54038-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)